Benjamin C. Lewis

Influence of mutations associated with Gilbert and Crigler–Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates

Wandee Udomuksorn, David J. Elliot, Benjamin C. Lewis et al. · Pharmacogenetics and Genomics · 2007 · 96 citations

Life Sciences, Genetics, Molecular Genetics +11

Mechanism-Based Inactivation of Human Cytochrome P4502C8 by Drugs in Vitro

Thomas M. Polasek, David J. Elliot, Benjamin C. Lewis et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 96 citations

Medicine, Pharmacokinetics, Pharmacology +16

MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1

Julie-Ann Hulin, Sara Tommasi, David J. Elliot et al. · Scientific Reports · 2017 · 78 citations · Full text

Medicine, Molecular Biology, Oncology +14

An evaluation of potential mechanism‐based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid

Thomas M. Polasek, David J. Elliot, Andrew A. Somogyi et al. · British Journal of Clinical Pharmacology · 2006 · 76 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +15

Electrochemical characterisation of the human cytochrome P450 CYP2C9

Daniel L. Johnson, Benjamin C. Lewis, David J. Elliot et al. · Biochemical Pharmacology · 2005 · 74 citations

Pharmacy, Biochemistry, Pharmacology +14